References
  1. Stokes MB, Valeri AM, Herlitz L, et al. Light chain proximal tubulopathy: clinical and pathologic characteristics in the modern treatment era. J Am Soc Nephrol. 2016;27(5):1555-1565. doi:10.1681/ASN.2015020185
  2. Vignon M, Javaugue V, Alexander MP, et al. Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients.Leukemia. 2017;31(1):123-129. doi:10.1038/leu.2016.195
  3. Wu X, Zhang L, Feng J, et al. Bortezomib-based chemotherapy can improve renal and tubular functions in patients with light chain-associated Fanconi syndrome. Ann Hematol.2019;98(5):1095-1100. doi:10.1007/s00277-018-3572-6
  4. Chen Z, Li J, Shi X, et al. Clinicopathological characteristics and long-term prognosis of monoclonal immunoglobulin light chain associated Fanconi syndrome. Ther Adv Hematol.2021;12:2040620720983127. doi:10.1177/2040620720983127
  5. Liu Y, Zhu T, Xu L, Qin Y, Zhuang J. A single-center case series of eight patients with the rare plasma cell dyscrasia of acquired Fanconi syndrome secondary to monoclonal gammopathy. Leuk Lymphoma.2015;56(11):3124-3128. doi:10.3109/10428194.2015.1025392
  6. Ma CX, Lacy MQ, Rompala JF, et al. Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma.Blood. 2004;104(1):40-42. doi:10.1182/blood-2003-10-3400
  7. Sirac C, Batuman V, Sanders PW. The proximal tubule toxicity of immunoglobulin light chains. Kidney Int Rep.2021;6(5):1225-1231. doi:10.1016/j.ekir.2021.02.026
  8. Sugimoto Y, Fujimoto M, Machida H, Nagaharu K, Murata T, Tsukada T. Light chain proximal tubulopathy diagnosed solely by electron microscopy of a renal biopsy specimen in a patient with monoclonal gammopathy of undetermined significance. Int J Hematol.2021;114(3):303-304. doi:10.1007/s12185-021-03193-9
  9. Feurstein S, Zoller J, Schwab C, et al. Concurrent light chain amyloidosis and proximal tubulopathy: insights into different aggregation behavior-A case report. EJHaem.2022;3(4):1377-1380. doi:10.1002/jha2.555
  10. Chopra R, Santana de Roberts R, Batal I, Batra S, Jim B. Light chain proximal tubulopathy with cast nephropathy in monoclonal gammopathy of renal significance. BMJ Case Rep. 2020;13(6):e234361. doi:10.1136/bcr-2020-234361
  11. Qin AB, Yu XJ, Zheng XZ, Wang SX, Zhou FD, Zhao MH. Lessons for the clinical nephrologist: a rare case with MGRS characterized by combined crystalline light chain proximal tubulopathy and crystal-storing histiocytosis responding to daratumumab. J Nephrol.2023;36(4):1203-1207. doi:10.1007/s40620-023-01584-1
  12. Ino A, Yamaguchi K, Taneda S, et al. Proximal tubulopathy with fibrillary inclusions: a rare manifestation of lymphoma-associated monoclonal gammopathy of renal significance (MGRS). Kidney Med.2019;1(6):397-401. doi:10.1016/j.xkme.2019.07.013
  13. Ugai T, Tsuda K, Sugihara H, et al. Renal Fanconi syndrome associated with monoclonal κ free light chain in a patient with Waldenström macroglobulinemia. Br J Haematol. 2013;162(1):1. doi:10.1111/bjh.12398
  14. Mathur M, Chacko B, Vankalakunti M, Patil C. Fanconi syndrome due to light chain proximal tubulopathy in a patient with multiple myeloma.Saudi J Kidney Dis Transpl. 2016;27(4):805-807. doi:10.4103/1319-2442.185268
  15. Chung EYM, McIlroy K, Fung C, Seshan SV, Moran S, Coleman PL. Glomerular, mesangial, and tubular cytoplasmic fibrillary inclusions in a patient with light-chain proximal tubulopathy. Nephron.2020;144(4):190-194. doi:10.1159/000505029
  16. Li MN, Zhao L, Li XH, et al. Autologous peripheral blood stem cell transplantation combined with bortezomib and dexamethasone for the treatment of light chain proximal tubulopathy: a case report.Zhonghua Xue Ye Xue Za Zhi. 2019;40(8):703. [Article in Chinese] doi:10.3760/cma.j.issn.0253-2727.2019.08.019
  17. Li F, Xie X, Sun L, Zhang Z, Chen J, Wang X. Non-crystalline light chain proximal tubulopathy associated with monoclonal gammopathy of renal significance: a case report and review of the literature.Clin Nephrol. 2023;99(1):32-40. doi:10.5414/CN110883
  18. Gutiérrez-Peredo GB, Filho JCBO, Montaño-Castellón I, Gutiérrez-Peredo AJ, Crusoé EQ, Gusmao-Flores D. Lambda light chain-induced monoclonal gammopathy of renal significance, manifesting with Fanconi syndrome and osteomalacia. BMC Nephrol. 2022;23(1):278. doi:10.1186/s12882-022-02901-9
  19. Tsuyuki T, Uramatsu T, Shimizu M, et al. Improvement of light chain proximal tubulopathy without crystals in IgGλ-type monoclonal gammopathy of undetermined significance using bortezomib and dexamethasone: a case report. Intern Med. 2023. doi:10.2169/internalmedicine.1835-23
  20. Kawamoto S, Hidaka Y, Kaneko Y, et al. Remission of light chain proximal tubulopathy in IgG λ-type multiple myeloma by lenalidomide and dexamethasone therapy. CEN Case Rep. 2019;8(3):159-165. doi:10.1007/s13730-019-00382-8
  21. Ikeda D, Matsue K. Non-crystalline light chain proximal tubulopathy without renal Fanconi syndrome in a patient with IgD-λ multiple myeloma. Br J Haematol. 2022;196(2):261. doi:10.1111/bjh.17785
  22. Kishi S, Obata F, Miki H, et al. Lambda light chain non-crystalline proximal tubulopathy with IgD lambda myeloma. Intern Med.2018;57(24):3597-3602. doi:10.2169/internalmedicine.1323-18
  23. Palladini G, Paiva B, Wechalekar A, et al. Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis. Blood Cancer J.2021;11(2):34. doi:10.1038/s41408-021-00428-0